Page 70 - AN-3-1
P. 70

Advanced Neurology                                           Dementia with Lewy bodies and substance misuse



                 doi: 10.1186/s13073-016-0296-x                155.  Lippai D, Bala S, Petrasek J, et al. Alcohol-induced IL-1β
                                                                    in the brain is mediated by NLRP3/ASC inflammasome
            145.  Chyan YJ, Poeggeler B, Omar RA,  et al. Potent
                 neuroprotective properties against the Alzheimer   activation that amplifies neuroinflammation. J Leukoc Biol.
                 beta-amyloid by an endogenous melatonin-related    2013;94(1):171-182.
                 indole  structure, indole-3-propionic acid.  J  Biol Chem.      doi: 10.1189/jlb.1212659
                 1999;274(31):21937-2142.
                                                               156.  Nennig SE, Schank JR. The role of NFkB in drug
                 doi: 10.1074/jbc.274.31.21937                      addiction: Beyond inflammation.  Alcohol Alcohol.
            146.  Navarrete  F,  García-Gutiérrez  MS,  Gasparyan  A,  et al.   2017;52(2):172-179.
                 Biomarkers of the endocannabinoid system in substance      doi: 10.1093/alcalc/agw098
                 use disorders. Biomolecules. 2022;12(3):396.
                                                               157.  He J, Crews FT. Increased MCP-1 and microglia in
                 doi: 10.3390/biom12030396                          various regions of the human alcoholic brain. Exp Neurol.
            147.  Li D, Yu S, Long Y,  et al. Tryptophan metabolism:   2008;210(2):349-358.
                 Mechanism-oriented therapy for neurological and      doi: 10.1016/j.expneurol.2007.11.017
                 psychiatric disorders. Front Immunol. 2022;13:985378.
                                                               158.  Fernandez-Lizarbe S, Pascual M, Guerri C. Critical role of
                 doi: 10.3389/fimmu.2022.985378                     TLR4 response in the activation of microglia induced by
            148.  Németh H, Toldi J, Vécsei L. Kynurenines, Parkinson’s Disease   ethanol. J Immunol. 2009;183(7):4733-4744.
                 and Other Neurodegenerative Disorders: Preclinical and Clinical      doi: 10.4049/jimmunol.0803590
                 Studies; 2006. p. 285-304. Available from: https://link.springer.
                 com/book/10.1007/978-3-211-45295-0?page=3#toc  159.  Qin L, Crews FT. NADPH oxidase and reactive oxygen
                                                                    species contribute to alcohol-induced microglial activation
                 doi: 10.1007/978-3-211-45295-0_45                  and neurodegeneration. J Neuroinflammation. 2012;9:5.
            149.  Tanaka M, Bohár Z, Martos D, Telegdy G, Vécsei L.      doi: 10.1186/1742-2094-9-5
                 Antidepressant-like effects of kynurenic acid in a modified
                 forced swim test. Pharmacol Rep. 2020;72(2):449-455.  160.  Erickson EK, Grantham EK, Warden AS, Harris RA.
                                                                    Neuroimmune signaling in alcohol use disorder.
                 doi: 10.1007/s43440-020-00067-5                    Pharmacol Biochem Behav. 2019;177:34-60.
            150.  Mechtcheriakov S, Gleissenthall GV, Geisler S, et al. Tryptophan-     doi: 10.1016/j.pbb.2018.12.007
                 kynurenine  metabolism  during  acute  alcohol  withdrawal
                 in patients with alcohol use disorder: The role of immune   161.  Sun E, Motolani A, Campos L, Lu T. The pivotal role of
                 activation. Alcohol Clin Exp Res. 2022;46(9):1648-1656.  NF-KB in the pathogenesis and therapeutics of Alzheimer’s
                                                                    disease Int. J Mol Sci. 2022;23(16):8972.
                 doi: 10.1111/acer.14920
                                                                    doi: 10.3390/ijms23168972
            151.  Montesinos  J,  Alfonso-Loeches  S,  Guerri C.  Impact  of
                 the innate immune response in the actions of ethanol   162.  Starr JM, Whalley LJ. Drug-induced dementia. Incidence,
                 on the central nervous system.  Alcohol Clin Exp Res.   management and prevention. Drug Saf. 1994;11:310-317.
                 2016;40(11):2260-2270.                             doi: 10.2165/00002018-199411050-00003
                 doi: 10.1111/acer.13208                       163.  Albert M. Neuropsychology of Alzheimer’s disease. Handb
            152.  Alfonso-Loeches S, Pascual-Lucas M, Blanco AM,    Clin Neurol. 2008;88:511-525.
                 Sanchez-Vera I, Guerri C. Pivotal role of TLR4 receptors      doi: 10.1016/S0072-9752(07)88027-4
                 in alcohol-induced neuroinflammation and brain damage.
                 J Neurosci. 2010;30(24):8285-8295.            164.  Kipps CM, Knibb JA, Patterson K, Hodges JR.
                                                                    Neuropsychology of frontotemporal dementia.  Handb
                 doi: 10.1523/JNEUROSCI.0976-10.2010
                                                                    Clin Neurol. 2008;88:527-548.
            153.  Porrini V, Pilotto A, Vezzoli M, et al. NF-κB/c-Rel DNA-     doi: 10.1016/S0072-9752(07)88028-6
                 binding is reduced in substantia nigra and peripheral
                 blood mononuclear cells of Parkinson’s disease patients.   165.  Marshall GA, Cummings JL. Neuropsychological
                 Neurobiol Dis. 2023;180:106067.                    evaluation in dementia. Handb Clin Neurol. 2008;89:53-61.
                 doi: 10.1016/j.nbd.2023.106067                     doi: 10.1016/S0072-9752(07)01204-3
            154.  Mincheva-Tasheva S, Soler RM. NF-κB signaling   166.  Costa A, Bagoj E, Monaco M, et al. Mini mental Parkinson
                 pathways: Role in nervous system physiology and    test standardization and normative data on an Italian
                 pathology. Neuroscientist. 2013;19(2):175-174.     sample. Neurol Sci. 2013;34(10):1797-1803.
                 doi: 10.1177/1073858412444007                      doi: 10.1007/s10072-013-1342-8


            Volume 3 Issue 1 (2024)                         18                        https://doi.org/10.36922/an.2232
   65   66   67   68   69   70   71   72   73   74   75